Mirati Therapeutics Our Commitment to Patients Mirati is dedicated to developing novel cancer therapeutics to improve and extend the lives of patients who are impacted by cancer. Patients are our guiding force. Their perseverance and resilience inspire us and fortifies our mission. As we advance our investigational therapies and strive to improve outcomes for patients living with cancer, we understand the critical need to gain insights from patients, their families and patient advocacy leaders. We have a deep appreciation for advocacy groups who are on the frontlines providing support to patients and families coping with the challenges of a cancer diagnosis. We support patient-focused groups aligned with our disease areas of focus, including lung cancer, pancreatic cancer, colorectal cancer and numerous other solid tumors. To identify clinical trials that match your diagnosis, treatment history and location, call 1-844-893-5530 or use our online Study Locator. Visit our Study Locator Clinical Trials At Mirati, clinical development programs are rigorously examined and our research is put to the test so we can help translate data into hope for patients with cancer. Learn about our clinical trials Expanded Access Policy Our goal is to provide access to our investigational therapies at the appropriate time and in the most clinically appropriate manner for patients. Read our expanded access policy Mirati Therapeutics © Copyright 2021 - Mirati Therapeutics, Inc. 858.332.3410 info@mirati.com Terms of Use Privacy Cookies Expanded Access Community Guidelines